122 related articles for article (PubMed ID: 27005521)
21. Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information.
Campbell JD; McQueen RB; Libby AM; Spackman DE; Carlson JJ; Briggs A
Med Decis Making; 2015 Jul; 35(5):596-607. PubMed ID: 25349188
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.
Fisher M; Walker A; Falqués M; Moya M; Rance M; Taylor D; Lindner L
Eur J Health Econ; 2016 Dec; 17(9):1091-1100. PubMed ID: 26728984
[TBL] [Abstract][Full Text] [Related]
23. [IQWiG's methods for the cost-benefit assessment : Comparison with an international reference scenario].
Schwalm A; Danner M; Seidl A; Volz F; Dintsios CM; Gerber A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):615-22. PubMed ID: 20449550
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis.
Koffijberg H; Knies S; Janssen MP
Value Health; 2018 Feb; 21(2):203-209. PubMed ID: 29477402
[TBL] [Abstract][Full Text] [Related]
25. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness acceptability curves--caveats quantified.
Jakubczyk M; Kamiński B
Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
[TBL] [Abstract][Full Text] [Related]
27. Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs.
Brisson M; Edmunds WJ
Med Decis Making; 2006; 26(5):434-46. PubMed ID: 16997923
[TBL] [Abstract][Full Text] [Related]
28. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
[TBL] [Abstract][Full Text] [Related]
29. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
[TBL] [Abstract][Full Text] [Related]
30. Analyzing cost-effectiveness of ulnar and median nerve transfers to regain forearm flexion.
Wali AR; Park CC; Brown JM; Mandeville R
Neurosurg Focus; 2017 Mar; 42(3):E11. PubMed ID: 28245686
[TBL] [Abstract][Full Text] [Related]
31. Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study.
Maru S; Byrnes JM; Carrington MJ; Stewart S; Scuffham PA
J Med Econ; 2017 Apr; 20(4):318-327. PubMed ID: 27841726
[TBL] [Abstract][Full Text] [Related]
32. Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables.
Baltussen RM; Hutubessy RC; Evans DB; Murray CJ
Int J Technol Assess Health Care; 2002; 18(1):112-9. PubMed ID: 11987434
[TBL] [Abstract][Full Text] [Related]
33. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management.
Grustam AS; Severens JL; De Massari D; Buyukkaramikli N; Koymans R; Vrijhoef HJM
Value Health; 2018 Jul; 21(7):772-782. PubMed ID: 30005749
[TBL] [Abstract][Full Text] [Related]
35. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
36. Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration.
Eeren HV; Schawo SJ; Scholte RH; Busschbach JJ; Hakkaart L
PLoS One; 2015; 10(7):e0131255. PubMed ID: 26146831
[TBL] [Abstract][Full Text] [Related]
37. Stochastic league tables: an application to diabetes interventions in the Netherlands.
Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
[TBL] [Abstract][Full Text] [Related]
38. Some Health States Are Better Than Others: Using Health State Rank Order to Improve Probabilistic Analyses.
Goldhaber-Fiebert JD; Jalal HJ
Med Decis Making; 2016 Nov; 36(8):927-40. PubMed ID: 26377369
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making.
Andronis L; Barton P; Bryan S
Health Technol Assess; 2009 Jun; 13(29):iii, ix-xi, 1-61. PubMed ID: 19500484
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
